Skip to content

Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy

Randomised Controlled Trial of Foam Sclerotherapy Versus Ambulatory Phlebectomy for the Treatment of Varicose Vein Tributaries

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03416413
Enrollment
160
Registered
2018-01-31
Start date
2018-02-01
Completion date
2025-06-30
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins

Brief summary

This study will be comparing the treatment of varicose vein tributaries using either foam sclerotherapy or ambulatory phlebectomies. Patients will be randomised to having either ambulatory phlebectomy (group A) or foam sclerotherapy (group B) following treatment of their saphenous vein. The re-intervention rates, safety, patient experience as well as the cost effectiveness of each intervention will be assessed.

Interventions

PROCEDUREAmbulatory phlebectomy

Minor surgery to remove varicose vein tributaries

Injection of foam sclerosant into varicose vein tributaries

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over 18 years of age * Symptomatic GSV or SSV vein reflux \> 0.5 seconds on colour Duplex * Varicose vein tributary requiring treatment

Exclusion criteria

* Current DVT * Recurrent varicose veins * Arterial disease (ABPI\<0.8) * Vein diameter \< 3mm * Preference for one of the treatment options * Patient who are unwilling to participate * Inability or unwillingness to complete questionnaires * Inability to attend follow-up appointments * Patient currently included in a study of varicose vein treatment

Design outcomes

Primary

MeasureTime frameDescription
Re-intervention rate12 monthsRe-intervention on varicose vein tributaries during study period

Secondary

MeasureTime frameDescription
Generic quality of life score12 monthsQuality of life score using the EuroQol's EQ-5D \[0=worse quality of life; 1=best quality of life\]
Disease-specific quality of life score12 monthsQuality of life score using the Aberdeen Varicose Vein Questionnaire (AVVQ) \[0=worse quality of life; 100= best quality of life\]
Disease specific quality of life score12 monthsQuality of life score using the ChronIc Venous Insufficiency Quality of Life Questionnaire (CIVIQ) \[0=worse quality of life; 100=best quality of life\]
Clinical score12 monthsClinical change using the Venous Clinical Severity Score (VCSS) \[0=least severe disease; 30=most severe disease\]
Pain score over the first 10 days2 weeksPain score over the first 10 days using a 0-100mm visual analogue scale (0=no pain; 100=worst pain)
Degree of bruising at 2 weeks2 weeksDegree of bruising at 2 weeks using a categorical 0-5 bruising scale (0=no bruising; 5=bruising extending beyond treated segment)
Time to return to normal activities2 weeks

Countries

United Kingdom

Contacts

Primary ContactAmjad Belramman
a.belramman17@imperial.ac.uk02033117335
Backup ContactRoshan Bootun
r.bootun@imperial.ac.uk02033117335

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026